BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Institute of Oncology
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250612T101500
DTEND;TZID=Europe/Paris:20250612T111500
DTSTAMP:20250523T091324Z
CREATED:20250407T123707Z
LAST-MODIFIED:20250523T091324Z
UID:49045-1749723300-1749726900@www.bricbordeaux.com
SUMMARY:Invited seminar - Romain PARENT - 12-06-2025
DESCRIPTION:Invited seminar by team 6 MIRCADE (Methods and Innovations for the Research in Pediatric Cancers.) headed by Christophe Grosset. \nRomain PARENT\nHepatitis Viruses & Liver Pathogenesis (PathLiv) Laboratory – UMR 1350\nInserm – Claude Bernard Lyon 1 University – Lyon Hepatology Institute \nThe interest of liver innervation in chronic liver disease and liver cancer. \nAbstract\nHepatocellular carcinoma (HCC) care has long been hampered by the enigmatic nature of disease onset across patients\, evolution\, as well as of response or resistance to treatment. Hepatic neural cells are likely the least studied liver cell type and mediate patients singularities from the ANS to the organ in real-time. These cells\, belonging to the autonomic nervous system (ANS)\, mediate liver/whole body crosstalk. Pathological innervation of the ANS has been identified in cancer\, nurturing tumor stroma and conferring stronger carcinogenic properties.\nIn this presentation focusing on a pathogenic continuum between normal liver and HCC\, we will present evidence for: (i) deep alterations of neural markers along this spectrum\, (ii) the presence of neural pools of cells in lesions\, (iii) the introduction of a novel neuronal score-based approach for stratification with respect to pathological and immunological considerations\, and (iv) functional studies causally demonstrating the interest of these notions for rational and accessible therapeutic intervention.     \n  \nBiography\nI obtained a PharmD at the U. of Aix-Marseille 1 in 2001 and a PhD in hepatic virology in 2004 through a PhD exchange program between the Center for the Study of Hepatitis C at the Rockefeller University of New-York and the Inserm Unit 271 in Lyon\, working on the early HCV tissue culture systems.\nI then spent four years at the Fred Hutchinson Cancer Research Center in Seattle working on HCV virology and cell translation. I obtained an Inserm CR2 position in 2009.\nI have been till then leading an independent group within Fabien Zoulim’s PathLiv laboratory\, gradually evolving from translational virology towards the study of liver innervation in pathology\, through a long term work on the axonal guidance cue netrin-1.\nMy group’s work on netrin-1 have ended up in the Phase III HCC-NET1 clinical trial which has for goal to target the axonal guidance factor netrin-1 in HCC. I recently obtained a Master degree in philosophy. As a teaching unit head at the Oncology Master of Lyon 1\, I also tackle these issues through the mind-body philosophical paradigm with the students.   \n 
URL:https://www.bricbordeaux.com/en/event/invited-seminar-romain-parent-12-06-2025/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2025/04/invited-seminar-romain-parent-2025-06-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250617T120000
DTEND;TZID=Europe/Paris:20250617T130000
DTSTAMP:20250602T131305Z
CREATED:20250602T131305Z
LAST-MODIFIED:20250602T131305Z
UID:49520-1750161600-1750165200@www.bricbordeaux.com
SUMMARY:Webinar “L’Heure Heka”: How Can You Tell If Research Results Have Innovation Potential?
DESCRIPTION:L’Heure Heka is a webinar series dedicated to the intersection of research\, innovation\, and impact. It is organized by SATT Aquitaine Science Transfert as part of the Pôles Universitaires d’Innovation (University Innovation Clusters): Bordeaux\, Sud-Aquitaine Innovation\, and Open Campus Innov. \n________________________________________________________________________ \nThe BRIC is in the spotlight for this 8th edition of L’Heure Heka. \nWhat are the early indicators that suggest a project has strong valorization potential?\nWhat obstacles do researchers face?\nWhat do researchers expect from early-stage support? \nOn Tuesday\, June 17\, 2025\, join us for a discussion on the valorization of research\, using the BRIC as a case study. But this isn’t just about healthcare!\nTogether with Grégoire PREVOST\, CEO of CIPREVO\, and Frédéric SALTEL\, Director of the BRIC\, we’ll explore the levers that help translate innovation from the lab into real-world impact. \nGrégoire PREVOST will share his insights from his experience as a “PUI Entrepreneur-in-Residence\,” a role he held for six months within the BRIC to raise awareness\, structure\, and support high-potential research projects. \nFrédéric SALTEL will provide his perspective as Director of the BRIC on the challenges and opportunities of such an approach. \n\nRegister here: https://blog.ast-innovations.com/fr/heure-heka
URL:https://www.bricbordeaux.com/en/event/webinar-lheure-heka-how-can-you-tell-if-research-results-have-innovation-potential/
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/webp:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2025/06/heure-heka-8-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250630T110000
DTEND;TZID=Europe/Paris:20250630T120000
DTSTAMP:20250617T140511Z
CREATED:20250617T140511Z
LAST-MODIFIED:20250617T140511Z
UID:49572-1751281200-1751284800@www.bricbordeaux.com
SUMMARY:Invited seminar - Jean-François Côté - 30-06-2025
DESCRIPTION:BRIC Team 3\, Liver Cancers and Tumor Invasion\, co-directed by Violaine Moreau and Frederic Saltel\, is pleased to invite Jean-François Côté\, President and Scientific Director of the Institut de recherches cliniques de Montréal (IRCM)\, Canada\, to present a seminar open to the scientific community.\nJean-François Côté is co-supervisor of Mélissa Correia De Oliveira‘s thesis\, team 3 BRIC. \n\nTitle : Mechanistic Insights into Tumour Growth\, Metastasis\, and Dormancy in Cancer Progression.\n\n\nAbstract\n\nMetastasis is the primary cause of cancer-related deaths\, yet the biological processes that enable tumor cells to spread\, survive in distant organs\, and eventually form secondary tumors remain incompletely understood. Gaining insight into these mechanisms is essential for developing strategies to prevent and treat metastatic disease across cancer types. \nIn the first part of my presentation\, I will discuss tumour dormancy in breast cancer. To uncover regulators of dormancy\, genome-wide CRISPR screens were performed on two breast cancer cell lines: 4T1 (short dormancy) and 4T07 (prolonged dormancy). 4T07 cells uniquely depended on class III PI3K (PIK3C3) and showed elevated mTORC1 activity via peripheral lysosome signaling. Inhibiting PIK3C3 suppressed this activity in both mouse and human models\, reduced metastasis in 4T07\, and eliminated dormant cells in a HER2-driven model. These results highlight PIK3C3-mTORC1 signaling as a potential therapeutic target to prevent metastatic relapse. In the second part of the presentation\, I will focus on RAS family proteins that regulates key signaling pathways involved in cell growth\, differentiation\, and survival. While canonical RAS proteins are well studied\, the broader group of 35 human RAS-related GTPases remains largely unexplored. Using proximity-dependent biotinylation (BioID) in three cell models\, we mapped interaction networks and subcellular localizations across the family. This generated a high-confidence interactome\, revealing thousands of spatially resolved associations. By analyzing nucleotide-state-specific variants\, we identified context-dependent interactions with effectors and regulators. Comparative clustering highlighted conserved and unique features across subfamilies. Integration with DepMap data uncovered essential crosstalk with regulators Rho GTPases and cytoskeletal dynamics in canonical RAS proteins. This resource advances our understanding of RAS-family signaling and its roles in development\, disease\, and cancer.            \n\n\n📆 Monday\, June 30\, 2025\, 11 a.m.\n📌 Conference room BBS (Bordeaux\, Biologie\, Santé)\,\n2 rue dr Hoffmann Martinot\, Bordeaux. Université de Bordeaux\, site Carreire
URL:https://www.bricbordeaux.com/en/event/invited-seminar-jean-francois-cote-30-06-2025/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2025/06/jean-francois-cote-2025-06-30.jpg
END:VEVENT
END:VCALENDAR